A C Farney

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Simultaneous cadaver pancreas living-donor kidney transplantation: a new approach for the type 1 diabetic uremic patient
    A C Farney
    Joseph and Corrine Schwartz Division of Transplantation and the Divisions of General Surgery and Urology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Ann Surg 232:696-703. 2000
  2. ncbi Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: a retrospective study
    B Philosophe
    Joseph and Corrine Schwartz Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Ann Surg 234:689-96. 2001
  3. ncbi The shrinking renal replacement therapy "break-even" point
    E J Schweitzer
    Department of Surgery, University of Maryland, Baltimore, USA
    Transplantation 66:1702-8. 1998
  4. ncbi Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice
    T Okitsu
    Division of Transplantation, University of Maryland School of Medicine, Baltimore, USA
    Am J Transplant 1:138-45. 2001
  5. ncbi Pulsatile pump perfusion of pancreata before human islet cell isolation
    D B Leeser
    Department of Transplant Surgery, University of Maryland Medical Center, Baltimore, Maryland 21012, USA
    Transplant Proc 36:1050-1. 2004
  6. ncbi Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation
    A K Sundberg
    Wake Forest University Baptist Medical Center, Winston Salem, North Carolina 27157 1095, USA
    Transplant Proc 37:1294-6. 2005
  7. ncbi Successful simultaneous kidney-pancreas transplantation from extreme donors
    R J Stratta
    Dept of General Surgery, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157 1095, USA
    Transplant Proc 37:3535-7. 2005
  8. ncbi Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage
    R P Singh
    Department of General Surgery and Nephrology, Wake Forest University Baptist Medical Center, Winston Salem, North Carolina 27157, USA
    Transplant Proc 40:502-5. 2008

Collaborators

Detail Information

Publications8

  1. ncbi Simultaneous cadaver pancreas living-donor kidney transplantation: a new approach for the type 1 diabetic uremic patient
    A C Farney
    Joseph and Corrine Schwartz Division of Transplantation and the Divisions of General Surgery and Urology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Ann Surg 232:696-703. 2000
    ..To review the authors' experience with a new approach for type I diabetic uremic patients: simultaneous cadaver-donor pancreas and living-donor kidney transplant (SPLK)...
  2. ncbi Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: a retrospective study
    B Philosophe
    Joseph and Corrine Schwartz Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Ann Surg 234:689-96. 2001
    ..To compare portal and systemic venous drainage of pancreas transplants and demonstrate an immunologic and survival superiority of portal venous drainage...
  3. ncbi The shrinking renal replacement therapy "break-even" point
    E J Schweitzer
    Department of Surgery, University of Maryland, Baltimore, USA
    Transplantation 66:1702-8. 1998
    ..This study examines the current cost of live donor (LD) transplantation at our institution, and compares it with that of dialysis...
  4. ncbi Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice
    T Okitsu
    Division of Transplantation, University of Maryland School of Medicine, Baltimore, USA
    Am J Transplant 1:138-45. 2001
    ..032). In conclusion, autoimmune processes facilitate the alloimmune response to minor and major histocompatibility antigens and accelerate graft destruction. The same autoimmune processes are more pronounced in the intraportal site...
  5. ncbi Pulsatile pump perfusion of pancreata before human islet cell isolation
    D B Leeser
    Department of Transplant Surgery, University of Maryland Medical Center, Baltimore, Maryland 21012, USA
    Transplant Proc 36:1050-1. 2004
    ..9 and 1.8 for the <8 hour and >8 hour CIT groups. This preliminary data indicates that low-flow machine pulsatile perfusion of pancreata with prolonged cold ischemia time can result in excellent yield, viability, and function...
  6. ncbi Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation
    A K Sundberg
    Wake Forest University Baptist Medical Center, Winston Salem, North Carolina 27157 1095, USA
    Transplant Proc 37:1294-6. 2005
    ....
  7. ncbi Successful simultaneous kidney-pancreas transplantation from extreme donors
    R J Stratta
    Dept of General Surgery, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157 1095, USA
    Transplant Proc 37:3535-7. 2005
    ..The purpose of this study was to retrospectively review our experience with "extreme" pancreas donors compared to conventional (CONV) donors...
  8. ncbi Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage
    R P Singh
    Department of General Surgery and Nephrology, Wake Forest University Baptist Medical Center, Winston Salem, North Carolina 27157, USA
    Transplant Proc 40:502-5. 2008
    ..Limited data are available on extended (EX) donor criteria in pancreatic transplantation (PTX)...